Literature DB >> 24184198

Activation and evasion of antiviral innate immunity by hepatitis C virus.

Stacy M Horner1.   

Abstract

Hepatitis C virus (HCV) chronically infects 130-170 million people worldwide and is a major public health burden. HCV is an RNA virus that infects hepatocytes within liver, and this infection is sensed as non-self by the intracellular innate immune response to program antiviral immunity to HCV. HCV encodes several strategies to evade this antiviral response, and this evasion of innate immunity plays a key role in determining viral persistence. This review discusses the molecular mechanisms of how the intracellular innate immune system detects HCV infection, including how HCV pathogen-associated molecular patterns are generated during infection and where they are recognized as foreign by the innate immune system. Further, this review highlights the key innate immune evasion strategies used by HCV to establish persistent infection within the liver, as well as how host genotype influences the outcome of HCV infection. Understanding these HCV-host interactions is key in understanding how to target HCV during infection and for the design of more effective HCV therapies at the immunological level.
© 2013.

Entities:  

Keywords:  HCV; MAM; MAVS; RIG-I; interferon

Mesh:

Substances:

Year:  2013        PMID: 24184198      PMCID: PMC4431647          DOI: 10.1016/j.jmb.2013.10.032

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  152 in total

Review 1.  The global burden of hepatitis C.

Authors:  Daniel Lavanchy
Journal:  Liver Int       Date:  2009-01       Impact factor: 5.828

2.  Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.

Authors:  Magdalena Sarasin-Filipowicz; Xueya Wang; Ming Yan; Francois H T Duong; Valeria Poli; Douglas J Hilton; Dong-Er Zhang; Markus H Heim
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

3.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

4.  Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.

Authors:  Dina Uzri; Lee Gehrke
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

Review 5.  The history of the "natural history" of hepatitis C (1968-2009).

Authors:  Leonard B Seeff
Journal:  Liver Int       Date:  2009-01       Impact factor: 5.828

6.  MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Authors:  Martin Baril; Marie-Eve Racine; François Penin; Daniel Lamarre
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

7.  Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA.

Authors:  Sua Myong; Sheng Cui; Peter V Cornish; Axel Kirchhofer; Michaela U Gack; Jae U Jung; Karl-Peter Hopfner; Taekjip Ha
Journal:  Science       Date:  2009-01-01       Impact factor: 47.728

8.  Translational insensitivity to potent activation of PKR by HCV IRES RNA.

Authors:  Takashi Shimoike; Sean A McKenna; Darrin A Lindhout; Joseph D Puglisi
Journal:  Antiviral Res       Date:  2009-05-23       Impact factor: 5.970

9.  The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors.

Authors:  Christopher S McAllister; Charles E Samuel
Journal:  J Biol Chem       Date:  2008-11-20       Impact factor: 5.157

10.  The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion.

Authors:  Ella R Hinson; Peter Cresswell
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

View more
  33 in total

Review 1.  Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

Authors:  Megha Haridas Upadya; Jude Juventus Aweya; Yee-Joo Tan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Targeting viperin to the mitochondrion inhibits the thiolase activity of the trifunctional enzyme complex.

Authors:  Arti B Dumbrepatil; Kelcie A Zegalia; Keerthi Sajja; Robert T Kennedy; E Neil G Marsh
Journal:  J Biol Chem       Date:  2020-01-24       Impact factor: 5.157

3.  Effect of P-body component Mov10 on HCV virus production and infectivity.

Authors:  Dandan Liu; Tanyaradzwa P Ndongwe; Maritza Puray-Chavez; Mary C Casey; Taisuke Izumi; Vinay K Pathak; Philip R Tedbury; Stefan G Sarafianos
Journal:  FASEB J       Date:  2020-06-04       Impact factor: 5.191

Review 4.  Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.

Authors:  Zhiyong Ma; Ejuan Zhang; Dongliang Yang; Mengji Lu
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

5.  Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.

Authors:  Peter D Krueger; Taeg S Kim; Sun-Sang J Sung; Thomas J Braciale; Young S Hahn
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

6.  Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.

Authors:  Martin Markowitz; Sherry Deren; Charles Cleland; Melissa La Mar; Evelyn Silva; Pedro Batista; Leslie St Bernard; Natanya Gettie; Kristina Rodriguez; Teresa H Evering; Haekyung Lee; Saurabh Mehandru
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

7.  Antiviral innate immunity: editorial overview.

Authors:  Eric O Freed; Michael Gale
Journal:  J Mol Biol       Date:  2014-01-22       Impact factor: 5.469

Review 8.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 10.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.